Gene and Cell Therapy's Unlimited Potential

Moderators

Roger Hajjar, MD

Director, Gene & Cell Therapy Institute, Mass General Brigham

Charlie Yang, PhD

Large/SMid-Cap Biotech and Major Pharma Analyst, BofA Global Research

Nathan Yozwiak, PhD

Head of Research, Gene and Cell Therapy Institute, Mass General Brigham

Panelists

Samarth Kulkarni, PhD

CEO, CRISPR Therapeutics

Peter Marks, MD, PhD

Director, Center for Biologics Evaluation and Research, FDA

Marcela Maus, MD, PhD

Director of Cellular Therapy and Paula O’Keeffe Chair in Cancer Research, Krantz Family Center for Cancer Research and Mass General Cancer Center;

Associate Director, Gene and Cell Therapy Institute, Mass General Brigham;

Associate Professor, Harvard Medical School

Joanne Smith-Farrell, PhD

CEO & Director, Be Biopharma